U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H18ClNO4S
Molecular Weight 379.858
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Z-335 Free Acid

SMILES

OC(=O)CC1=CC=C2CC(CNS(=O)(=O)C3=CC=C(Cl)C=C3)CC2=C1

InChI

InChIKey=PNAKMOCXPDQBOS-UHFFFAOYSA-N
InChI=1S/C18H18ClNO4S/c19-16-3-5-17(6-4-16)25(23,24)20-11-13-8-14-2-1-12(10-18(21)22)7-15(14)9-13/h1-7,13,20H,8-11H2,(H,21,22)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats.
2003-01
Patents
Name Type Language
1H-Indene-5-acetic acid, 2-[[[(4-chlorophenyl)sulfonyl]amino]methyl]-2,3-dihydro-
Preferred Name English
Z-335 Free Acid
Code English
2-[[[(4-Chlorophenyl)sulfonyl]amino]methyl]-2,3-dihydro-1H-indene-5-acetic acid
Systematic Name English
2-{2-[(4-chlorobenzenesulfonamido)methyl]-2,3-dihydro-1H-inden-5-yl}acetic acid
Systematic Name English
Code System Code Type Description
CAS
146737-36-2
Created by admin on Wed Apr 02 21:10:39 GMT 2025 , Edited by admin on Wed Apr 02 21:10:39 GMT 2025
PRIMARY
FDA UNII
LM4TK5EY6B
Created by admin on Wed Apr 02 21:10:39 GMT 2025 , Edited by admin on Wed Apr 02 21:10:39 GMT 2025
PRIMARY
PUBCHEM
219052
Created by admin on Wed Apr 02 21:10:39 GMT 2025 , Edited by admin on Wed Apr 02 21:10:39 GMT 2025
PRIMARY